0001493152-20-022415.txt : 20201124 0001493152-20-022415.hdr.sgml : 20201124 20201124162105 ACCESSION NUMBER: 0001493152-20-022415 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201124 DATE AS OF CHANGE: 20201124 EFFECTIVENESS DATE: 20201124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-381437 FILM NUMBER: 201344427 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 D 1 primary_doc.xml X0708 D LIVE 0001321834 Akers Biosciences, Inc. 201 GROVE ROAD THOROFARE NJ NEW JERSEY 08086 (856) 848-8698 NEW JERSEY None Akers Biosciences Inc Corporation true Stuart Benson 201 Grove Road Thorofare NJ NEW JERSEY 08086 Executive Officer Chief Financial Officer Christopher C. Schreiber 201 Grove Road Thorofare NJ NEW JERSEY 08086 Executive Officer Director President and Chief Executive Officer Joshua Silverman 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Chairman of the Board of Directors Bill J. White 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Robert C. Schroeder 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Other Health Care Decline to Disclose 06b false 2020-11-11 false true true false 0 Katalyst Securities LLC 112494 None None 630 THIRD AVENUE 5TH FLOOR NEW YORK NY NEW YORK 10017 CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK OH OHIO PA PENNSYLVANIA SD SOUTH DAKOTA false 18067000 18067000 0 Represents 9,765,933 shares of common stock or pre-funded warrants and warrants to purchase 9,765,933 shares of common stock at $2.06 per share. false 56 1174355 0 In addition to the sales commission noted above, the placement agent also received a warrant to purchase 390,368 shares of Issuer's common stock at $1.85 per share. 0 false Akers Biosciences, Inc. /s/ Stuart Benson Stuart Benson Chief Financial Officer 2020-11-24